The PIGT Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 3 (MCAHS3) genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the PIGT gene, which can lead to the development of MCAHS3. This syndrome is a rare genetic disorder characterized by a spectrum of symptoms including multiple congenital anomalies, muscle hypotonia (reduced muscle tone), and seizures, among others. The genetic test plays a crucial role in the early diagnosis and management of the syndrome, allowing for timely intervention and support for affected individuals.
The test is conducted through a detailed analysis of the patient's DNA to detect abnormalities in the PIGT gene that are indicative of MCAHS3. This is crucial for understanding the specific genetic alterations in an individual, which can help in tailoring personalized treatment and management plans. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the PIGT gene.
By opting for this genetic test at DNA Labs UAE, patients and their families can gain valuable insights into the genetic underpinnings of the syndrome, facilitating informed decisions regarding care and management. It is an important step towards improving the quality of life for individuals with MCAHS3 through targeted interventions and support.
The NFU1 Gene Multiple Mitochondrial Dysfunctions Syndrome Type 1 Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE. Priced at 4400 AED, this test is designed to identify mutations in the NFU1 gene, which are associated with Multiple Mitochondrial Dysfunctions Syndrome Type 1 (MMDS1). MMDS1 is a rare genetic disorder characterized by a wide range of symptoms, including developmental delay, neurological deterioration, and metabolic abnormalities, stemming from impaired mitochondrial function.
Mitochondria are known as the powerhouses of the cell, and their dysfunction can lead to severe and often life-threatening conditions. The NFU1 gene plays a crucial role in the biosynthesis of iron-sulfur (Fe-S) clusters, essential components for mitochondrial energy production. Mutations in the NFU1 gene disrupt this process, leading to the symptoms observed in MMDS1.
The test conducted at DNA Labs UAE involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific mutations in the NFU1 gene. This genetic test is critical for early diagnosis, which can significantly influence the management and treatment strategies for affected individuals. Early intervention may include dietary modifications, supplements, and supportive therapies aimed at improving quality of life and mitigating the progression of symptoms.
In summary, the NFU1 Gene Multiple Mitochondrial Dysfunctions Syndrome Type 1 Genetic Test is a valuable diagnostic tool for identifying the genetic cause of MMDS1, facilitating early and effective management of the disorder. Offered at DNA Labs UAE for 4400 AED, this test represents a crucial step towards personalized care for individuals with this rare mitochondrial condition.
The BOLA3 Gene Multiple Mitochondrial Dysfunctions Syndrome Type 2 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect mutations in the BOLA3 gene. These mutations are known to cause Multiple Mitochondrial Dysfunctions Syndrome Type 2 (MMDS2), a rare genetic disorder characterized by a wide range of clinical symptoms, including severe metabolic abnormalities, developmental delay, and lactic acidosis. The condition stems from impaired function of the mitochondrial respiratory chain, crucial for energy production in cells.
The test is conducted using a sample of the patient's blood or saliva, from which DNA is extracted and analyzed for specific genetic alterations in the BOLA3 gene. This precise approach enables healthcare providers to make an accurate diagnosis, essential for managing the condition effectively.
Priced at 4400 AED, the test is a significant investment in understanding and addressing this complex disorder. Conducted at the state-of-the-art facilities of DNA Labs UAE, patients can expect a high standard of accuracy and reliability in their test results, providing essential information for the management of MMDS2. This genetic test is a crucial tool for families seeking answers to unexplained symptoms related to mitochondrial dysfunction, offering a pathway towards tailored treatment and management plans.
The IBA57 Gene Multiple Mitochondrial Dysfunctions Syndrome Type 3 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the IBA57 gene. These mutations are associated with Multiple Mitochondrial Dysfunctions Syndrome Type 3 (MMDS3), a rare genetic disorder that impacts mitochondrial function, leading to a range of severe clinical manifestations, including neurological and developmental abnormalities.
This test is crucial for individuals suspected of having MMDS3, as it provides a definitive diagnosis by analyzing the genetic makeup of the patient for specific mutations in the IBA57 gene. Early and accurate diagnosis is essential for managing symptoms, potential interventions, and genetic counseling for affected families.
DNA Labs UAE, a leading facility in genetic testing, offers this comprehensive genetic test at a cost of 4400 AED. The test is conducted using advanced genomic technologies to ensure high accuracy and reliability of results, making it a valuable tool for affected individuals and their families seeking answers and options for managing this complex condition.
The ISCA2 Gene Multiple Mitochondrial Dysfunctions Syndrome Type 4 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect mutations in the ISCA2 gene. These mutations are associated with Multiple Mitochondrial Dysfunctions Syndrome Type 4, a rare genetic condition that affects mitochondrial function, leading to a range of symptoms including developmental delay, muscle weakness, and metabolic abnormalities. The test is crucial for early diagnosis and management of the condition. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately identify the genetic alterations in the ISCA2 gene. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a significant step forward in the genetic diagnosis and personalized medicine for patients with suspected mitochondrial disorders.
The ACTA2 gene multisystemic smooth muscle dysfunction syndrome genetic test is a specialized diagnostic tool used to identify mutations in the ACTA2 gene, which can lead to a range of health issues affecting the smooth muscles throughout the body. This condition, known as multisystemic smooth muscle dysfunction syndrome, can manifest in various forms, including vascular disease, lung problems, and urinary tract issues, among others. Early detection through this genetic test can be crucial for managing symptoms and preventing severe complications.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 4400 AED, an investment in health that provides individuals and families with vital information for managing the condition and planning for the future. DNA Labs UAE utilizes state-of-the-art technology to ensure accurate and reliable results, offering a comprehensive analysis of the ACTA2 gene for any mutations that may be present.
The MSTN Gene Muscle Hypertrophy Genetic Test, available at DNA Labs UAE for 3200 AED, is a cutting-edge diagnostic tool designed to analyze the myostatin (MSTN) gene, which plays a critical role in regulating muscle growth. Myostatin is a protein that inhibits muscle growth, and variations in the MSTN gene can lead to reduced myostatin activity, resulting in increased muscle mass and strength, a condition known as muscle hypertrophy. This test is particularly relevant for athletes, fitness enthusiasts, and individuals interested in understanding their genetic predisposition to muscle development. By identifying specific genetic markers, the test can provide insights into one's potential for muscle growth, enabling tailored training and nutrition programs. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures confidentiality, accuracy, and comprehensive analysis, making it a valuable tool for those aiming to optimize their physical performance and body composition based on their genetic blueprint.
The POMK gene is associated with a rare genetic disorder known as Muscle-Eye-Brain Disease (MEB), which is characterized by muscle weakness, structural eye defects, and brain abnormalities. Mutations in the POMK gene disrupt the normal development of these organs, leading to the symptoms observed in individuals with MEB. The POMK-related genetic test is a specialized diagnostic tool designed to identify mutations in the POMK gene, providing crucial information for the diagnosis and management of Muscle-Eye-Brain Disease.
Performed at DNA Labs UAE, the test involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the POMK gene. This genetic testing is vital for confirming the diagnosis of MEB, understanding the risk of passing the condition to future generations, and guiding treatment and management decisions.
The cost of the POMK-related genetic test at DNA Labs UAE is 4400 AED. This cost covers the full process of the genetic analysis, from sample collection to the provision of a detailed report explaining the test results. It's important for patients to consult with their healthcare provider to understand the implications of the test results and the best course of action following diagnosis.
The LAMA2 gene muscular dystrophy Type 1A genetic test is a specialized diagnostic procedure aimed at detecting mutations in the LAMA2 gene, which are indicative of Muscular Dystrophy Type 1A, also known as Merosin-deficient congenital muscular dystrophy. This condition is characterized by muscle weakness and wasting, primarily affecting the voluntary muscles used for activities such as crawling and walking. Early detection through genetic testing is crucial for managing symptoms, planning treatment strategies, and providing genetic counseling for affected families.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific mutations in the LAMA2 gene. The presence of these mutations can confirm a diagnosis of Muscular Dystrophy Type 1A, enabling healthcare providers to tailor interventions more effectively and offer support to families dealing with the implications of this genetic condition.
The cost of the LAMA2 gene muscular dystrophy Type 1A genetic test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of obtaining a definitive diagnosis and the potential to significantly impact the patient's treatment plan and quality of life can be invaluable. Patients considering this test are encouraged to discuss it with their healthcare provider to fully understand its benefits and implications.
The FKRP gene muscular dystrophy type 1C genetic test is a specialized diagnostic procedure aimed at identifying mutations in the FKRP gene, which are known to cause a form of limb-girdle muscular dystrophy (LGMD1C). This condition is characterized by progressive weakness and wasting of the muscles around the hips and shoulders, affecting mobility and physical capabilities over time. The test involves analyzing the patient's DNA to pinpoint any genetic abnormalities in the FKRP gene, which plays a crucial role in muscle function and integrity.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test is priced at 4400 AED. This cost encompasses the full process of sample collection, genetic sequencing, and expert analysis to ensure accurate identification of any mutations associated with the condition. The results from this test are critical for confirming a diagnosis of LGMD1C, which can then guide treatment options and genetic counseling for affected individuals and their families. This genetic test is a key step towards personalized care, offering insights into the specific genetic alterations driving the disease and enabling targeted management strategies.
